Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2026 May 1];5(6):s51. Available from: https://skin.dermsquared.com/skin/article/view/1402